Clopid-As Tablet
by Drug International Limited
৳12.00
Beximco Pharmaceuticals Ltd.
Odrel Plus from Beximco Pharma Ltd & Generic is Clopidogrel 75mg + Aspirin 75mg. It is suitable for reducing the occurrence of myocardial infarction (MI) and stroke. It is used to reduce the incidence of myocardial infarction and stroke in patients with ST-elevation myocardial infarction (STEMI). For patients with confirmed peripheral artery disease or recent myocardial infarction (MI) or a history of recent stroke, it can reduce the incidence of myocardial infarction and stroke.
In patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation Myocardial Infarction (NSTEMI)] and acute ST-segment elevation ACS [ST-elevation Myocardial Infarction (STEMI)], it is advised to reduce the rate of Myocardial Infarction (MI) and Stroke.
Recent MI, recent Stroke, or existing Peripheral Arterial Disease: It is advised to reduce the rate of MI and Stroke in patients with established peripheral arterial disease or a history of recent Myocardial Infarction (MI) or recent Stroke.
Clopidogrel is a prodrug that is used to treat blood clots. The irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets suppresses platelet activation and aggregation. At 2 hours after single oral dosages, dose-dependent suppression of platelet aggregation can be noticed. On the first day, repeated 75 mg doses decrease ADP-induced platelet aggregation, and inhibition achieves a stable state between Days 3 and 7.
Aspirin prevents platelet aggregation by inhibiting platelet cyclooxygenase irreversibly, preventing the production of thromboxane A2, a potent inducer of platelet aggregation and vasoconstriction.
The recommended oral dose is one tablet daily.
Oral anticoagulants, NSAIDs, Metamizole, SSRIs, CYP2C19 inhibitors increase the risk of bleeding. It shows interaction with Tonofovir, Valproic acid, Varicella vaccine, Acetazolamide and Nicorandil.
This combination is contraindicated in the following conditions: Hypersensitivity to the drug substance or any component of the product. Active pathological bleeding such as peptic ulcer or intracranial hemorrhage.
This combination is generally well tolerated.
In pregnant women, there are no sufficient and well-controlled trials. It should only be taken if absolutely necessary throughout the first and second trimesters of pregnancy. During the third trimester of pregnancy, it is not recommended. Clopidogrel is not known to be excreted in human breast milk, however it is known to be excreted in human milk. During breast-feeding, this drug should be avoided.
Anti-platelet drugs
Protect from light and moisture by storing in a cool, dry place below 30°C. Keep out of children's reach.
by Healthcare Pharmaceuticals Limited
৳12.00